oral semaglutide 50 mg of #semaglutide daily was associated with body weight reduction and improved cardiometabolic risk factors in East Asian adults with overweight or #obesity, with or without type 2 #diabetes. https://ja.ma/41sPiYj What to Know About Semaglutide:

Ozempic (semaglutide) is a GLP-1 receptor agonist approved for adults with type 2 diabetes to help manage blood sugar, to lower the risk of heart attack and stroke in those with heart disease, and to reduce the risk of kidney failure and worsening kidney disease in those with chronic kidney disease

Labs and clinician guidance still come first

Because levels of TMAO in the blood are strongly linked to dietary intake, dietary modifications can be a significant way to reduce risk. Because the metabolism of white meat, seafood, dairy and plant-based proteins, in particular, leads to less production of TMAO, they should comprise the majority of your protein sources

It responds

Online Follow-Up Appointments Available Sometimes there are obstacles to coming into a medical office, but help is still available

[11] studied the influence of GLP-1RAs on the presence of RGC measured by gastric ultrasound and defined as the presence of solids, thick liquids, or more than 1.5 mL kg 1 of clear liquids